Investing in Sudeep Pharma IPO has sparked varying opinions among different brokerage firms. According to Master Capital Services, the market for food, nutrition, and pharmaceuticals favors investment in Sudeep Pharma. GIOJIT Investment has refrained from making negative comments about investing in the company, though its valuation is considered high. Nevertheless, some brokerage firms express confidence in the company for the long term. GMP rates have fluctuated over time for Sudeep Pharma, reaching as high as 130 and now stabilizing around 86. With the upper band at 593, investing in GMP could potentially yield around 14% profit.
Is Sudeep Pharma IPO Worth Investing In? What Does GMP Say?
-
Flamengo and PSG have faced each other three times; check out their record
-
Indonesia Open Footgolf Tournament: Comedian Oki Rengga Admits Addiction, Wants to Become a Professional Athlete
-
Shameful Incident in Punjab! Landlord Rolls Tenant’s Daughter
-
Virgil van Dijk Expresses Desire for Mohamed Salah to Stay at Liverpool
Deixe um comentário